The discovery of placenta growth factor and its biological activity

被引:352
作者
De Falco, Sandro [1 ,2 ]
机构
[1] CNR, Angiogenesis Lab, Inst Genet & Biophys Adriano Buzzati Traverso, I-80131 Naples, Italy
[2] CNR, Stem Cell Fate Lab, Inst Genet & Biophys Adriano Buzzati Traverso, I-80131 Naples, Italy
关键词
angiogenesis inducing agents; anoxia; endothelial cells; hypoxia; macrophages; neovascularization; pathologic; placenta growth factor; vascular endothelial growth factors; BONE-MARROW MICROENVIRONMENT; HYPOXIA-INDUCIBLE FACTOR-1; ADIPOSE-TISSUE DEVELOPMENT; ALPHA-CONVERTING ENZYME; FACTOR GENE-EXPRESSION; TRANSCRIPTION FACTOR-I; 5 UNTRANSLATED REGION; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; CARDIAC-HYPERTROPHY;
D O I
10.3858/emm.2012.44.1.025
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Angiogenesis is a complex biological phenomenon crucial for a correct embryonic development and for post-natal growth. In adult life, it is a tightly regulated process confined to the uterus and ovary during the different phases of the menstrual cycle and to the heart and skeletal muscles after prolonged and sustained physical exercise. Conversly, angiogenesis is one of the major pathological changes associated with several complex diseases like cancer, atherosclerosis, arthritis, diabetic retinopathy and age-related macular degeneration. Among the several molecular players involved in angiogenesis, some members of VEGF family, VEGF-A, VEGF-B and placenta growth factor (PIGF), and the related receptors VEGF receptor 1 (VEGFR-1, also known as Flt-1) and VEGF receptor 2 (VEGFR-2, also known as Flk-1 in mice and KDR in human) have a decisive role. In this review, we describe the discovery and molecular characteristics of PIGF, and discuss the biological role of this growth factor in physiological and pathological conditions.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 94 条
[1]
Placenta growth factor and vascular endothelial growth factor are co-expressed during early embryonic development [J].
Achen, MG ;
Gad, JM ;
Stacker, SA ;
Wilks, AF .
GROWTH FACTORS, 1997, 15 (01) :69-+
[2]
Adini A, 2002, CANCER RES, V62, P2749
[3]
INHIBITION OF TRANSLATION OF TRANSFORMING GROWTH FACTOR-BETA-3 MESSENGER-RNA BY ITS 5' UNTRANSLATED REGION [J].
ARRICK, BA ;
LEE, AL ;
GRENDELL, RL ;
DERYNCK, R .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (09) :4306-4313
[4]
Role of PIGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 [J].
Autiero, M ;
Waltenberger, J ;
Communi, D ;
Kranz, A ;
Moons, L ;
Lambrechts, D ;
Kroll, J ;
Plaisance, S ;
De Mol, M ;
Bono, F ;
Kliche, S ;
Fellbrich, G ;
Ballmer-Hofer, K ;
Maglione, D ;
Mayr-Beyrle, U ;
Dewerchin, M ;
Dombrowski, S ;
Stanimirovic, D ;
Van Hummelen, P ;
Dehio, C ;
Hicklin, DJ ;
Persico, G ;
Herbert, JM ;
Communi, D ;
Shibuya, M ;
Collen, D ;
Conway, EM ;
Carmeliet, P .
NATURE MEDICINE, 2003, 9 (07) :936-943
[5]
PlGF Blockade Does Not Inhibit Angiogenesis during Primary Tumor Growth [J].
Bais, Carlos ;
Wu, Xiumin ;
Yao, Jenny ;
Yang, Suya ;
Crawford, Yongping ;
McCutcheon, Krista ;
Tan, Christine ;
Kolumam, Ganesh ;
Vernes, Jean-Michel ;
Eastham-Anderson, Jeffrey ;
Haughney, Peter ;
Kowanetz, Marcin ;
Hagenbeek, Thijs ;
Kasman, Ian ;
Reslan, Hani Bou ;
Ross, Jed ;
Van Bruggen, Nick ;
Carano, Richard A. D. ;
Meng, Yu-Ju Gloria ;
Hongo, Jo-Anne ;
Stephan, Jean-Philippe ;
Shibuya, Masabumi ;
Ferrara, Napoleone .
CELL, 2010, 141 (01) :166-177
[6]
Intracellular pathways triggered by the selective FLT-1-agonist placental growth factor in vascular smooth muscle cells exposed to hypoxia [J].
Bellik, L ;
Vinci, MC ;
Filippi, S ;
Ledda, F ;
Parenti, A .
BRITISH JOURNAL OF PHARMACOLOGY, 2005, 146 (04) :568-575
[7]
Placenta growth factor: Identification and characterization of a novel isoform generated by RNA alternative splicing [J].
Cao, YH ;
Ji, WDR ;
Qi, P ;
Rosin, A ;
Cao, YM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 235 (03) :493-498
[8]
Positive and Negative Modulation of Angiogenesis by VEGFR1 Ligands [J].
Cao, Yihai .
SCIENCE SIGNALING, 2009, 2 (59) :re1
[9]
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions [J].
Carmeliet, P ;
Moons, L ;
Luttun, A ;
Vincenti, V ;
Compernolle, V ;
De Mol, M ;
Wu, Y ;
Bon, F ;
Devy, L ;
Beck, H ;
Scholz, D ;
Acker, T ;
DiPalma, T ;
Dewerchin, M ;
Noel, A ;
Stalmans, I ;
Barra, A ;
Blacher, S ;
Vandendriessche, T ;
Ponten, A ;
Eriksson, U ;
Plate, KH ;
Foidart, JM ;
Schaper, W ;
Charnock-Jones, DS ;
Hicklin, DJ ;
Herbert, JM ;
Collen, D ;
Persico, MG .
NATURE MEDICINE, 2001, 7 (05) :575-583
[10]
Molecular mechanisms and clinical applications of angiogenesis [J].
Carmeliet, Peter ;
Jain, Rakesh K. .
NATURE, 2011, 473 (7347) :298-307